Capstone Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,900
Closed -$548K 1688
2022
Q2
$548K Hold
13,900
﹤0.01% 1202
2022
Q1
$972K Buy
+13,900
New +$1.02M ﹤0.01% 1340

Other funds holding EXAS

Capstone Investment Advisors's EXAS Position: Q1 2026 in Review

Capstone Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 251,384 shares — an estimated $25.5M sold.

Capstone Investment Advisors first reported a position in EXAS in Q2 2017 and held it in 9 quarters. The position peaked at $25.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Capstone Investment Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 251,384 Exact Sciences shares in Q1 2026, an estimated $25.5M.
  • Capstone Investment Advisors first reported a position in Exact Sciences in Q2 2017 and held it in 9 quarters.
  • Capstone Investment Advisors's Exact Sciences position peaked at $25.5M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.